§ COMPARE REGULATORS

NMPA vs Fimea: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of NMPA (China) vs Fimea (Finland).

NMPA

National Medical Products Administration (China)

China

China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing

CLASSES

Class I, II, III

PATHWAY

NMPA Registration (CMDE review)

KEY FUNCTIONS
  • CMDE technical review
  • MAH (Marketing Authorization Holder) system
  • In-country testing requirements
  • Clinical trial oversight
  • NMPA registration certificates

Fimea

Fimea — Finland Medical Device Regulatory Authority

Finland

Fimea is the national regulatory authority responsible for medical device oversight in Finland. It manages device registration, market surveillance, and adverse event reporting within the Europe regul

CLASSES

EU MDR classes

PATHWAY

Fimea registration

KEY FUNCTIONS
  • Device registration
  • Market surveillance
  • Adverse event reporting
  • Import/export control

MedFlux monitors both NMPA and Fimea in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS